Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Insulin Resistance and Oxidative Stress in the Brain: What’s New?
Mateusz Maciejczyk, Ewa Żebrowska, Adrian Chabowski
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 4, pp. 874-874
Open Access | Times Cited: 203

Showing 1-25 of 203 citing articles:

NOX4 promotes ferroptosis of astrocytes by oxidative stress-induced lipid peroxidation via the impairment of mitochondrial metabolism in Alzheimer's diseases
Min Woo Park, Hyeon Woo, Junhyung Kim, et al.
Redox Biology (2021) Vol. 41, pp. 101947-101947
Open Access | Times Cited: 429
Hormones and oxidative stress: an overview
G.B.N. Chainy, Dipak Kumar Sahoo
Free Radical Research (2019) Vol. 54, Iss. 1, pp. 1-26
Closed Access | Times Cited: 188
Nutrition Management in Older Adults with Diabetes: A Review on the Importance of Shifting Prevention Strategies from Metabolic Syndrome to Frailty
Yoshiaki Tamura, Takuya Omura, Kenji Toyoshima, et al.
Nutrients (2020) Vol. 12, Iss. 11, pp. 3367-3367
Open Access | Times Cited: 167
The brain as an insulin-sensitive metabolic organ
Joshua L. Milstein, Heather A. Ferris
Molecular Metabolism (2021) Vol. 52, pp. 101234-101234
Open Access | Times Cited: 147
Cognitive impairment and type 2 diabetes mellitus: Focus of SGLT2 inhibitors treatment
Maria Rosaria Rizzo, Irene Di Meo, Rita Polito, et al.
Pharmacological Research (2022) Vol. 176, pp. 106062-106062
Open Access | Times Cited: 105
Targeting Metabolic Diseases: The Role of Nutraceuticals in Modulating Oxidative Stress and Inflammation
Aida Dama, Kleva Shpati, Patricia Daliu, et al.
Nutrients (2024) Vol. 16, Iss. 4, pp. 507-507
Open Access | Times Cited: 36
Antioxidant Barrier, Redox Status, and Oxidative Damage to Biomolecules in Patients with Colorectal Cancer. Can Malondialdehyde and Catalase Be Markers of Colorectal Cancer Advancement?
Justyna Dorf, Mateusz Maciejczyk, Konrad Zaręba, et al.
Biomolecules (2019) Vol. 9, Iss. 10, pp. 637-637
Open Access | Times Cited: 102
Salivary Antioxidant Barrier, Redox Status, and Oxidative Damage to Proteins and Lipids in Healthy Children, Adults, and the Elderly
Mateusz Maciejczyk, Anna Zalewska, Jerzy Robert Ładny
Oxidative Medicine and Cellular Longevity (2019) Vol. 2019, pp. 1-12
Open Access | Times Cited: 101
Empagliflozin Improves Insulin Sensitivity of the Hypothalamus in Humans With Prediabetes: A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Trial
Stephanie Kullmann, Julia Hummel, Róbert Wágner, et al.
Diabetes Care (2021) Vol. 45, Iss. 2, pp. 398-406
Open Access | Times Cited: 73
Incretin and insulin signaling as novel therapeutic targets for Alzheimer’s and Parkinson’s disease
Joseph Nowell, Eleanor G Blunt, Paul Edison
Molecular Psychiatry (2022) Vol. 28, Iss. 1, pp. 217-229
Open Access | Times Cited: 66
A Potential Link Between Visceral Obesity and Risk of Alzheimer’s Disease
Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, Abdulrahman A. Alsayegh, et al.
Neurochemical Research (2022) Vol. 48, Iss. 3, pp. 745-766
Closed Access | Times Cited: 54
Significance of Brain Glucose Hypometabolism, Altered Insulin Signal Transduction, and Insulin Resistance in Several Neurological Diseases
Enrique Blázquez, Verónica Hurtado-Carneiro, Yannick Le Baut Ayuso, et al.
Frontiers in Endocrinology (2022) Vol. 13
Open Access | Times Cited: 52
Insulin resistance in ischemic stroke: Mechanisms and therapeutic approaches
Peng-Fei Ding, Huasheng Zhang, Jie Wang, et al.
Frontiers in Endocrinology (2022) Vol. 13
Open Access | Times Cited: 45
Insulin and Its Key Role for Mitochondrial Function/Dysfunction and Quality Control: A Shared Link between Dysmetabolism and Neurodegeneration
Giacoma Galizzi, Marta Di Carlo
Biology (2022) Vol. 11, Iss. 6, pp. 943-943
Open Access | Times Cited: 41
Inside the diabetic brain: Insulin resistance and molecular mechanism associated with cognitive impairment and its possible therapeutic strategies
Bhaskar Jyoti Dutta, Shamsher Singh, Sanket Seksaria, et al.
Pharmacological Research (2022) Vol. 182, pp. 106358-106358
Closed Access | Times Cited: 41
The Role of Glucagon-Like Peptide-1 Receptor Agonists (GLP-1 RA) in Diabetes-Related Neurodegenerative Diseases
Dihe Cheng, Shuo Yang, Xue Zhao, et al.
Drug Design Development and Therapy (2022) Vol. Volume 16, pp. 665-684
Open Access | Times Cited: 40
How Can Insulin Resistance Cause Alzheimer’s Disease?
Ji Hye Yoon, JooHyun Hwang, Sung Un Son, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 4, pp. 3506-3506
Open Access | Times Cited: 35
The Molecular Mechanisms of the Relationship between Insulin Resistance and Parkinson’s Disease Pathogenesis
Viviana A. Ruiz‐Pozo, Rafael Tamayo‐Trujillo, Santiago Cadena-Ullauri, et al.
Nutrients (2023) Vol. 15, Iss. 16, pp. 3585-3585
Open Access | Times Cited: 28
Type 2 Diabetes and Alzheimer’s Disease: The Emerging Role of Cellular Lipotoxicity
Nicola Marrano, Giuseppina Biondi, Anna Borrelli, et al.
Biomolecules (2023) Vol. 13, Iss. 1, pp. 183-183
Open Access | Times Cited: 25
Diet’s Role in Modifying Risk of Alzheimer’s Disease: History and Present Understanding
William B. Grant, Steven M. Blake
Journal of Alzheimer s Disease (2023) Vol. 96, Iss. 4, pp. 1353-1382
Open Access | Times Cited: 25
The roles of dietary polyphenols at crosstalk between type 2 diabetes and Alzheimer's disease in ameliorating oxidative stress and mitochondrial dysfunction via PI3K/Akt signaling pathways
Jingwen Wang, Jingyang Zhang, Zhi‐Ling Yu, et al.
Ageing Research Reviews (2024) Vol. 99, pp. 102416-102416
Closed Access | Times Cited: 13
Brain insulin resistance mediated cognitive impairment and neurodegeneration: Type-3 diabetes or Alzheimer’s Disease
Abhilasha Ahlawat, Vaibhav Walia, Munish Garg
Acta Neurologica Belgica (2025)
Closed Access | Times Cited: 1
Down Syndrome Is a Metabolic Disease: Altered Insulin Signaling Mediates Peripheral and Brain Dysfunctions
Mara Dierssen, Marta Fructuoso, Maria Martínez de Lagrán, et al.
Frontiers in Neuroscience (2020) Vol. 14
Open Access | Times Cited: 68
Salivary Redox Biomarkers in Different Stages of Dementia Severity
Anna Klimiuk, Mateusz Maciejczyk, Magdalena Choromańska, et al.
Journal of Clinical Medicine (2019) Vol. 8, Iss. 6, pp. 840-840
Open Access | Times Cited: 65
Obesity and Alzheimer’s disease: Molecular bases
Pasquale Picone, Marta Di Carlo, Domenico Nuzzo
European Journal of Neuroscience (2020) Vol. 52, Iss. 8, pp. 3944-3950
Closed Access | Times Cited: 62
Page 1 - Next Page

Scroll to top